Brief: Lexicon Announces Receipt Of Complete Response Letter For Zynquista (Sotagliflozin)
20/12/2024 21:55
Dec 20 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O :
* LEXICON ANNOUNCES RECEIPT OF COMPLETE RESPONSE LETTER FOR
ZYNQUISTA™ (SOTAGLIFLOZIN)
* LEXICON PHARMACEUTICALS INC - TO DISCONTINUE ZYNQUISTA
LAUNCH
PREPARATIONS
Source text: ID:nGNX5RYqVS
Further company coverage: LXRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lexicon Pharmaceuticals
See all newsLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Lexicon Pharmaceuticals posts Q2 net loss
Brief: Lexicon Pharmaceuticals Q2 EPS USD -0.07
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview